Loading...
ALXP
ALSAF
Market cap129kUSD
Jun 30, Last price  
0.64EUR
Name

Safe SA

Chart & performance

D1W1MN
ALXP:ALSAF chart
P/E
—
P/S
0.02
EPS
—
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
14.83%
Div Yld LY
—
Div Yld TTM
—
Revenues
5m
5,400,000
Net income
-4m
-4,099,999
CFO
-2m
-2,013,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Operating as a medical technology firm, Safe Orthopaedics SA specializes in the creation and global distribution of sterile implants and disposable surgical tools designed to address spinal fracture conditions. Its innovative product line includes SteriSpine PS, a comprehensive system for managing both spinal fractures and degenerative spine issues. Additionally, they provide SteriSpine VA, a versatile suite encompassing pre-packaged Kyphoplasty and Cement solutions. The portfolio further extends to SteriSpine LC, offering pre-assembled instrumentation for lumbar cages like Cedar and Elm, and SteriSpine CC, which provides similar ready-to-use instruments for cervical cages, exemplified by Walnut. Established in 2010, the company's main operations are based in Éragny-sur-Oise, France.

Key people

Alain Coudray
Independent Chairman of the Board
Pierre Dumouchel
Chief Executive Officer · since 2016
Francois-Henri Reynaud
Chief Financial and Administrative Officer
Sjors Hermans
Senior Vice President of Sales
Sven Claes
Director of Marketing
Katy Fraisse
Director of Human Resources
Thomas Droulout
Technical Director
Stephanie Robert
Director of Quality and Reglemantary Affairs
Marie-Yvonne Landel-Meunier
Independent Director · since 2015
Dominique Petit
Independent Director · since 2018
IPO date
Feb 10, 2015
Employees
138
Domiciled in
FR
Incorporated in
FR
Headquarters & legal address
80 RUE DE MONTEPY
ZA DE MONTEPY
FLEURIEUX-SUR-L'ARBRESLE 69210
FR

Valuation

Title
EUR in thousands, except ratios and share amounts
FY
2025‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT